Effect of an oral absorbent AST-120 in late-stage chronic kidney disease (CKD) patients
Phase of Trial: Phase IV
Latest Information Update: 06 May 2014
At a glance
- Drugs Charcoal (Primary) ; Methoxy polyethylene glycol-epoetin beta
- Indications Renal failure
- Focus Therapeutic Use
- 06 May 2014 New trial record
- 08 Apr 2014 Primary endpoint 'Renal-function' has been met.
- 08 Apr 2014 Results published in the Nephrology Dialysis Transplantation.